seniovo GmbH has raised US$4.48 million in a Series B growth financing
In order to support seniovo’s plans to launch a comprehensive B2B platform, the company was looking for a strategic partner for its expansion. The aim was to position itself as a central service provider on the market via a partner ecosystem.
Since 2017, seniovo GmbH has been offering all services related to barrier-free bathroom conversions. The company is a unique provider of the entire value chain and is currently continuing to develop into a comprehensive platform for the barrier-free home and for other care services and products. The service portfolio ranges from planning and applying for subsidies to approvals, conversion and billing. In addition to in-house services, the company works with partners, such as craftsmen, to carry out conversions on site. Seniovo generated revenues of approximately US$2.4 million in 2021 and has 35 full-time employees.
Oaklins’ team in Germany, in its role as fundraising and sell-side advisor, assisted seniovo’s team and shareholders in this process.
Sprechen Sie mit dem Deal-Team
Transaktionen
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Mehr erfahrenTekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.
Mehr erfahrenDie Bayer AG hat eine Übernahmevereinbarung mit Cara Care geschlossen
Die Bayer AG, bekannt für vielfältige Innovationen in den Bereichen Gesundheit und Life Science, hat die Übernahme von Cara Care (HiDoc Technologies GmbH) vereinbart, für die im Oktober 2024 ein Insolvenzverfahren eröffnet worden war. Cara Care, eine innovative digitale Gesundheitsplattform und offizielle DiGA, passt perfekt zu Bayers strategischem Fokus auf digitale Gesundheit und die Erweiterung seines Lösungsportfolios. Der Abschluss der Transaktion wird für das Frühjahr 2025 erwartet.
Mehr erfahren